Johnson & Johnson to Acquire Firefly Bio for $1 Billion to Expand Oncology Pipeline
Johnson & Johnson Acquires Firefly Bio for $1 Billion to Expand Oncology Pipeline Johnson & Johnson (JNJ) announced its $1 billion acquisition of Firefly Bio, a biotech firm specializing in ... Read More